https://orcid.org/0000-0002-4750-1422Dr. Inman is a rheumatologist and Senior Scientist, recognized for his expertise in autoimmune diseases, particularly spondyloarthritis (SpA) and ankylosing spondylitis (AS). Based at the University of Toronto and Toronto Western Hospital, he has led extensive research into the genetic, immunologic, and clinical mechanisms driving these inflammatory conditions, which affect the spine, joints, and other organs.
Dr. Inman's research contributions are diverse, encompassing the genetic basis of susceptibility to AS, the identification of immune pathways involved in disease progression, and the development of new biomarkers to assess disease activity and treatment response. His work has led to a better understanding of how genetic and environmental factors interact to trigger and sustain inflammation in these diseases, and he has been instrumental in advancing the field of precision medicine for SpA. Additionally, he has contributed significantly to the development of novel therapeutics aimed at modulating the immune system and reducing chronic inflammation in AS patients.
An advocate for patient-centered care, Dr. Inman has also pioneered approaches for early diagnosis and treatment, aiming to improve quality of life and long-term outcomes for individuals with SpA. His work is widely published and has shaped clinical practice guidelines for managing AS, making him a highly respected leader in rheumatology research and patient care.